Literature DB >> 17961087

Stem cell therapy for joint problems using the horse as a clinically relevant animal model.

Thomas G Koch1, Dean H Betts.   

Abstract

Research into articular cartilage is a surprisingly recent endeavour and much remains to be learned about the normal development of the synovial joint and its components that interplay in osteoarthritis and focal cartilage defects. Stem cell research is likely to contribute to the understanding of the developmental biology of synovial joints and their pathologies. Before human clinical trials are undertaken, stem cell-based therapies for non-life threatening disorders should be evaluated for their safety and efficacy using animal models of spontaneous disease and not solely by the existing laboratory models of experimentally induced lesions. The horse lends itself as a good animal model of spontaneous joint disorders that are clinically relevant to similar human disorders. Equine stem cell and tissue engineering studies may be financially feasible to principal investigators and small biotechnology companies if the equine industry is successfully engaged in the research process.

Entities:  

Mesh:

Year:  2007        PMID: 17961087     DOI: 10.1517/14712598.7.11.1621

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  15 in total

1.  Combined use of platelet rich plasma & micro-fat in sport and race horses with degenerative joint disease: preliminary clinical study in eight horses.

Authors:  Fabrizio Bembo; Julia Eraud; Cecile Philandrianos; Baptiste Bertrand; Alain Silvestre; Julie Veran; Florence Sabatier; Guy Magalon; Jeremy Magalon
Journal:  Muscles Ligaments Tendons J       Date:  2016-09-17

Review 2.  Animal models for cartilage regeneration and repair.

Authors:  Constance R Chu; Michal Szczodry; Stephen Bruno
Journal:  Tissue Eng Part B Rev       Date:  2010-02       Impact factor: 6.389

3.  Virally and physically transgenized equine adipose-derived stromal cells as a cargo for paracrine secreted factors.

Authors:  Gaetano Donofrio; Antonio Capocefalo; Valentina Franceschi; Giorgio Morini; Maurizio Del Bue; Virna Conti; Sandro Cavirani; Stefano Grolli
Journal:  BMC Cell Biol       Date:  2010-09-23       Impact factor: 4.241

Review 4.  Concepts for the clinical use of stem cells in equine medicine.

Authors:  Thomas G Koch; Lise C Berg; Dean H Betts
Journal:  Can Vet J       Date:  2008-10       Impact factor: 1.008

5.  MicroRNA29a Treatment Improves Early Tendon Injury.

Authors:  Ashlee E Watts; Neal L Millar; Josh Platt; Susan M Kitson; Moeed Akbar; Raquel Rech; Jay Griffin; Roy Pool; Tom Hughes; Iain B McInnes; Derek S Gilchrist
Journal:  Mol Ther       Date:  2017-07-28       Impact factor: 11.454

6.  Fetal derived embryonic-like stem cells improve healing in a large animal flexor tendonitis model.

Authors:  Ashlee E Watts; Amy E Yeager; Oleg V Kopyov; Alan J Nixon
Journal:  Stem Cell Res Ther       Date:  2011-01-27       Impact factor: 6.832

7.  Inflammatory mediators and cartilage biomarkers in synovial fluid after a single inflammatory insult: a longitudinal experimental study.

Authors:  Janny C de Grauw; Chris H A van de Lest; Paul René van Weeren
Journal:  Arthritis Res Ther       Date:  2009-03-09       Impact factor: 5.156

8.  The horse as a model of naturally occurring osteoarthritis.

Authors:  C W McIlwraith; D D Frisbie; C E Kawcak
Journal:  Bone Joint Res       Date:  2012-11-01       Impact factor: 5.853

9.  Regenerative therapies for equine degenerative joint disease: a preliminary study.

Authors:  Sarah Broeckx; Marieke Zimmerman; Sara Crocetti; Marc Suls; Tom Mariën; Stephen J Ferguson; Koen Chiers; Luc Duchateau; Alfredo Franco-Obregón; Karin Wuertz; Jan H Spaas
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

10.  Stemness Signature of Equine Marrow-derived Mesenchymal Stem Cells.

Authors:  Morteza Zahedi; Abbas Parham; Hesam Dehghani; Hossein Kazemi Mehrjerdi
Journal:  Int J Stem Cells       Date:  2017-05-30       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.